In June of this year, the new crown inactivated vaccines developed by the Beijing Institute of Sinopharm and Beijing Kexing Zhongwei were approved by the drug regulatory department and can be vaccinated for people aged 3-17. In an interview with the Global Times reporter at the end of August, Zhang Yuntao, chief scientist and vice president of Sinopharm, said that from clinical trials and current vaccination data, inactivated vaccines are very safe for people aged 3-17. Zhang Yuntao believes that the vaccination of this group of people should be strengthened, because most of them are students, and the school personnel are relatively concentrated, and it is very important to provide them with protection.
A domestic immunology expert told the Global Times reporter on the 14th that due to the overall arrangement of my country’s new crown vaccination, there is currently no vaccination for people aged 3-12, but the conditions are available in terms of technology and ability. Vaccination can be carried out for elementary school students. The expert emphasized that all the vaccines currently approved for use by minors in my country are inactivated vaccines, and their safety has been verified by clinical trials and real-world studies. Parents should not have too much worry, as long as there are no serious diseases, Allergy to vaccine components is contraindicated. Vaccination for minors is as safe and effective as adults.